{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:00:07Z","timestamp":1787014807406,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1688,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1111\/j.1524-4733.2008.00351.x","type":"journal-article","created":{"date-parts":[[2008,5,16]],"date-time":"2008-05-16T18:17:11Z","timestamp":1210961831000},"page":"1120-1130","source":"Crossref","is-referenced-by-count":7,"title":["Sociodemographic and Clinical Correlates of Utility Scores in Alzheimer's Disease"],"prefix":"10.1016","volume":"11","author":[{"given":"Edward Alan","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lon S.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Zbrozek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Rosenheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1524-4733.2008.00351.x_bib10","series-title":"Neuropsychopharmacology: The Fifth Generation of Progress","article-title":"Cost-effectiveness of therapeutics for Alzheimer's Disease","author":"Manca","year":"2002"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib20","series-title":"Alzheimer's Disease Facts and Figures, 2007","author":"Alzheimer's Association","year":"2007"},{"issue":"Suppl. 9","key":"10.1111\/j.1524-4733.2008.00351.x_bib30","first-page":"S3","article-title":"Diagnosis and treatment of Alzheimer's disease","volume":"64","author":"Grossberg","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib40","series-title":"Mental Health: A Report of the Surgeon General","author":"U.S. Department of Health and Human Services","year":"1999"},{"issue":"Suppl. 1","key":"10.1111\/j.1524-4733.2008.00351.x_bib50","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1212\/WNL.51.1_Suppl_1.S53","article-title":"Dementia caregiver burden: a review of the literature and guidelines for assessment and intervention","volume":"51","author":"Dunkin","year":"1998","journal-title":"Neurology"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00002093-200107000-00004","article-title":"The association between caregiver burden and caregiver health-related quality of life in Alzheimer's disease","volume":"15","author":"Bell","year":"2001","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib70","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","article-title":"Alzheimer disease in the US population","volume":"60","author":"Hebert","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib80","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev.publhealth.23.100901.140525","article-title":"The public health impact of Alzheimer's disease, 2000\u20132050: potential implications of treatment advances","volume":"23","author":"Sloane","year":"2002","journal-title":"Ann Rev Public Health"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib90","first-page":"1365","article-title":"Pharmacologic treatment of Alzheimer's disease: an update","volume":"68","author":"Delagarza","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.wad.0000201847.29836.a5","article-title":"Efficacy and safety of memantine in moderate-to-severe Alzheimer's disease: the evidence to date","volume":"20","author":"Bullock","year":"2006","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib110","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archneur.55.11.1409","article-title":"The efficacy of Ginko biloba on cognitive function in Alzheimer's disease","volume":"55","author":"Oken","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib120","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","article-title":"A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study","volume":"336","author":"Sano","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(96)03356-9","article-title":"Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease","volume":"348","author":"Tang","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib140","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMoa010178","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease","volume":"351","author":"In t' Veld","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib150","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa061240","article-title":"Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease","volume":"355","author":"Schneider","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib160","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2165\/00019053-200321140-00003","article-title":"Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease","volume":"21","author":"Jonsson","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib170","series-title":"The Clinical and Cost-Effectiveness of Donepezil, Rivastigmine, Galantamine, and Memantine for Alzheimer's Disease","author":"Loveman","year":"2006"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib180","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1176\/ps.48.11.1440","article-title":"Methods of cost-effectiveness analysis in the assessment of new drugs for Alzheimer's disease","volume":"48","author":"Neumann","year":"1997","journal-title":"Psychiatr Ser"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib190","series-title":"Cost Effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"issue":"Suppl. 3","key":"10.1111\/j.1524-4733.2008.00351.x_bib200","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/00005650-198903001-00003","article-title":"The quality of well-being scale: applications in AIDS, cystic fibrosis, and arthritis","volume":"27","author":"Kaplan","year":"1989","journal-title":"Med Care"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2014A new facility for the measurement of health related quality of life","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib220","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2165\/00019053-199507060-00005","article-title":"Multi-attribute preference functions: health utilities index","volume":"7","author":"Torrance","year":"1995","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1477-7525-3-57","article-title":"Application of a disease-specific mapping function to estimate utility gains with effective treatment of schizophrenia","volume":"3","author":"Lenert","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00005650-199901000-00005","article-title":"Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers","volume":"37","author":"Neumann","year":"1999","journal-title":"Med Care"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1014406429385","article-title":"Content validity for dementia of three generic preference based health related quality of life instruments","volume":"11","author":"Silberfeld","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib260","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/0272989X06288685","article-title":"Assessing health state utilities in elderly patients at cardiovascular risk","volume":"26","author":"Winkelmayer","year":"2006","journal-title":"Med Decis Making"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib270","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s11136-005-5745-8","article-title":"A study of the construct validity of the Health Utilities Index Mark 3 (HUI3) in patients with schizophrenia","volume":"15","author":"Luo","year":"2006","journal-title":"Qual Life Res"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib280","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/B:QURE.0000018479.52075.bf","article-title":"Is the Health Utilities Index valid in total hip arthroplasty patients?","volume":"13","author":"Blanchard","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib290","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1167\/iovs.05-0072","article-title":"The impact of age-related macular degeneration on health status utility values","volume":"46","author":"Espallargues","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib300","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1023\/B:QURE.0000018497.06539.8f","article-title":"Construct validity of the RAND-12 and Health Utilities Index Mark 2 and 3 in type 2 diabetes","volume":"13","author":"Maddigan","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib310","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11136-004-3928-3","article-title":"Responsiveness of generic health-related quality of life measures in stroke","volume":"14","author":"Pickard","year":"2005","journal-title":"Qual Life Res"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-3-44","article-title":"Methodology and measurement properties of health-related quality of life instruments: a prospective study of patients undergoing reduction surgery","volume":"3","author":"Thoma","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib330","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0165-1781(96)02797-7","article-title":"Quality of well-being in late-life psychosis","volume":"63","author":"Patterson","year":"1996","journal-title":"Psychiatry Res"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib340","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/089826439801000103","article-title":"Validity of the quality of well being scale for patients with Alzheimer's disease","volume":"10","author":"Kerner","year":"1998","journal-title":"J Aging Health"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib350","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11136-005-4364-8","article-title":"Utility-based quality of life measures in Alzheimer's disease","volume":"15","author":"Naglie","year":"2006","journal-title":"Qual Life Res"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib360","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/0272989X0002000405","article-title":"A comparison of HUI2 and HUI3 utility scores in Alzheimer's disease","volume":"20","author":"Neumann","year":"2000","journal-title":"Med Decis Making"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib370","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.wad.0000201851.52707.c9","article-title":"Patient- and proxy-reported utility in Alzheimer disease using EuroQol","volume":"20","author":"Jonsson","year":"2006","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib380","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/00019053-200523060-00002","article-title":"Health utilities in Alzheimer's disease and implications for cost-effectiveness analysis","volume":"23","author":"Neumann","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/appi.ajgp.9.4.346","article-title":"National Institute of Mental Health Clinical Antipsychotic Trials in Intervention Effectiveness (CATIE): Alzheimer's disease trial methodology","volume":"9","author":"Schneider","year":"2001","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib400","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/archpsyc.64.11.1259","article-title":"Cost-benefit analysis of second generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer disease","volume":"64","author":"Rosenheck","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib410","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1212\/WNL.52.6.1138","article-title":"Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease","volume":"52","author":"Neumann","year":"1999","journal-title":"Neurology"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib420","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib430","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib440","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/geronj\/39.2.194","article-title":"The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research. II. Representative profile patterns","volume":"39","author":"Beller","year":"1984","journal-title":"J Gerontol"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib450","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib460","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop","volume":"43","author":"Roman","year":"1993","journal-title":"Neurology"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib470","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005650-200202000-00006","article-title":"Multiattribute and single attribute utility functions for the Health Utilities Index Mark 3 system","volume":"40","author":"Feeny","year":"2002","journal-title":"Med Care"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib480","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1017\/S1041610200006359","article-title":"Tracking cognitive decline in Alzheimer's disease using the Mini-Mental State Examination: a meta-analysis","volume":"12","author":"Han","year":"2000","journal-title":"Int Psychogeriatr"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib490","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00019442-200506000-00004","article-title":"A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease","volume":"13","author":"Craig","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib500","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1136\/jnnp.2004.056408","article-title":"Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia","volume":"76","author":"Fuh","year":"2007","journal-title":"J Neurosurg Psychiatry"},{"issue":"Suppl.","key":"10.1111\/j.1524-4733.2008.00351.x_bib510","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer's disease","volume":"22","author":"Galasko","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib520","doi-asserted-by":"crossref","first-page":"M216","DOI":"10.1093\/geronj\/49.5.M216","article-title":"Assessing patient dependence in Alzheimer's disease","volume":"49","author":"Stern","year":"1994","journal-title":"J Gerontol Med Sci"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib530","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archneur.59.8.1304","article-title":"Longitudinal assessment of patient dependence in Alzheimer Disease","volume":"59","author":"Brickman","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib540","first-page":"33","article-title":"Concepts and methods in the development of the ADRQL. An instrument for assessing health-related quality of life in persons with Alzheimer's disease","volume":"5","author":"Rabins","year":"1999","journal-title":"J Mental Health Aging"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib550","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00002093-199206030-00001","article-title":"Quality of life and dementia","volume":"6","author":"Whitehouse","year":"1992","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib560","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1017\/S1041610205002073","article-title":"The concept of quality of life in dementia in the different stages of the disease","volume":"17","author":"Ettema","year":"2006","journal-title":"Int Psychogeriatr"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib570","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1099-1166(200002)15:2<181::AID-GPS96>3.0.CO;2-I","article-title":"Quality of life of patients with dementia in long-term care","volume":"15","author":"Gonzalez-Salvador","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib580","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/gps.796","article-title":"A follow-up study of change in quality of life among persons with dementia residing in a long-term care facility","volume":"18","author":"Lyketsos","year":"2003","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib590","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archpsyc.60.7.737","article-title":"Treating depression in Alzheimer's disease: efficacy and safety of sertraline therapy and the benefits of depression reduction: the DIADS","volume":"60","author":"Lyketsos","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib600","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/01.mlr.0000182493.57090.c1","article-title":"Self-reported health status of the general adult US population as assessed by the EQ-5D and Health Utilities Index","volume":"43","author":"Luo","year":"2005","journal-title":"Med Care"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib610","doi-asserted-by":"crossref","first-page":"M523","DOI":"10.1093\/gerona\/57.8.M523","article-title":"Low cognitive performance, comorbid disease, and task-specific disability: findings from a nationally representative survey","volume":"57A","author":"Blaum","year":"2002","journal-title":"J Gerontol"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib620","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00019442-200503000-00011","article-title":"General-medical conditions in older patients with serious mental illness","volume":"13","author":"Kilbourne","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib630","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.MLR.0000093480.58308.D8","article-title":"Mapping the SF-12 to preference-based instruments: convergent validity in a low-income, minority population","volume":"41","author":"Franks","year":"2003","journal-title":"Med Care"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib640","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/0272989X04264015","article-title":"Predicting EuroQoL EQ-5D preference scores from the SF-12 health survey in a nationally representative sample","volume":"24","author":"Lawrence","year":"2004","journal-title":"Med Decis Making"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0272989X9701700101","article-title":"Predicting quality of well-being scores from the SF-36","volume":"17","author":"Fryback","year":"1997","journal-title":"Med Decis Making"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib660","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/02729890122062352","article-title":"Evaluating quality-adjusted life years. Estimation of the Health Utility Index (HUI2) from the SF-36","volume":"21","author":"Nichol","year":"2001","journal-title":"Med Decis Making"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib670","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.JGP.0000192478.82189.a8","article-title":"Mapping scores onto stages. Mini-Mental State Examination and Clinical Dementia Rating","volume":"14","author":"Perneczky","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib680","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1017\/S0266462303000321","article-title":"Comparing community-preference-based and direct standard gamble utility scores: evidence from elective total hip arthroplasty","volume":"19","author":"Feeny","year":"2003","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib690","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7525-4-25","article-title":"Do visual analogue scale (VAS) derived standard gamble (SG) utilities agree with Health Utilities Index utilities? A comparison of patient and community preferences for health status in rheumatoid arthritis patients","volume":"4","author":"Rashidi","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib700","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00005650-200108000-00003","article-title":"EQ-5D in patients with dementia: an investigation of inter-rater agreement","volume":"39","author":"Councill","year":"2001","journal-title":"Med Care"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib710","first-page":"308","article-title":"Why don't Americans use cost-effectiveness analysis?","volume":"10","author":"Neumann","year":"2004","journal-title":"Am J Manag Care"},{"key":"10.1111\/j.1524-4733.2008.00351.x_bib720","author":"Coalition for Health Services Research"},{"issue":"Suppl. 1","key":"10.1111\/j.1524-4733.2008.00351.x_bib730","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1080\/713650013","article-title":"The health and long-term care policy challenges of Alzheimer's disease","volume":"5","author":"Riggs","year":"2001","journal-title":"Aging Mental Health"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510605943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510605943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T12:27:11Z","timestamp":1546000031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301510605943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":73,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1098301510605943"],"URL":"https:\/\/doi.org\/10.1111\/j.1524-4733.2008.00351.x","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}